Khanam Farhana, Islam Md Taufiqul, Bhuiyan Taufiqur Rahman, Hossen Md Ismail, Rajib Md Nazmul Hasan, Haque Shahinur, Ireen Mahzabeen, Qudrat-E-Khuda Syed, Biswas Prasanta Kumar, Bhuiyan Md Amirul Islam, Islam Kamrul, Rahman Nazia, Alam Raz S M Azadul, Mosharraf Md Parvej, Shawon Bhuiyan Md Elias, Islam Sadia, Ahmed Dilruba, Ahmmed Faisal, Zaman Khalequ, Clemens John D, Qadri Firdausi
Infectious Diseases Division, International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh.
Director General Office, International Vaccine Institute, Seoul, Republic of Korea.
Open Forum Infect Dis. 2024 Mar 25;11(Suppl 1):S76-S83. doi: 10.1093/ofid/ofad653. eCollection 2024 Mar.
is an important cause of diarrhea in Bangladeshi children <5 years of age, with an incidence rate of 4.6 per 100 person-years. However, the report was more than a decade old, and data on consequences are similarly outdated and heterogeneously collected.
Facility-based disease surveillance is planned to be carried out under the Enterics for Global Health (EFGH) Surveillance Study consortium for 2 years with aims to optimize and standardize laboratory techniques and healthcare utilization and coverage survey, clinical and anthropometric data collection, safety monitoring and responsiveness, and other related activities. The EFGH is a cohesive network of multidisciplinary experts, capable of operating in concert to conduct the study to generate data that will pave the way for potential vaccine trials in settings with high disease burden. The study will be conducted within 7 country sites in Asia, Africa, and Latin America.
We outline the features of the Bangladesh site as part of this multisite surveillance network to determine an updated incidence rate and document the consequences of diarrhea in children aged 6-35 months, which will help inform policymakers and to implement the future vaccine trials.
是孟加拉国5岁以下儿童腹泻的一个重要病因,发病率为每100人年4.6例。然而,该报告已有十多年历史,关于其后果的数据同样过时且收集方式各异。
计划在全球健康肠道疾病(EFGH)监测研究联盟下开展为期2年的基于机构的疾病监测,旨在优化和规范实验室技术、医疗保健利用及覆盖情况调查、临床和人体测量数据收集、安全监测与反应能力以及其他相关活动。EFGH是一个由多学科专家组成的紧密网络,能够协同开展研究以生成数据,为疾病负担高的地区进行潜在疫苗试验铺平道路。该研究将在亚洲、非洲和拉丁美洲的7个国家站点进行。
作为这个多站点监测网络的一部分,我们概述了孟加拉国站点的特征,以确定最新发病率并记录6至35个月大儿童腹泻的后果,这将有助于为政策制定者提供信息并实施未来的疫苗试验。